EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 20th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc. • Delaware
This EXECUTIVE EMPLOYMENT AGREEMENT dated as of January 1, 2023 (“Agreement”) is by and between JIM ROGERS (“Executive”) and TEMPUS LABS, INC. (“Company”).
SECOND AMENDMENT TO CREDIT AGREEMENTCredit Agreement • May 20th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc. • New York
This CREDIT AGREEMENT is entered into as of September 22, 2022, by and among TEMPUS LABS, INC., a Delaware corporation (the “Borrower”), the Lenders party hereto from time to time, ARES CAPITAL CORPORATION, as Administrative Agent, and ARES CAPITAL MANAGEMENT LLC, as Lead Arranger and Bookrunner.
TWELFTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 20th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc. • Delaware
This TWELFTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of April 30, 2024, by and among Tempus AI, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of whom is referred to in this Agreement as an “Investor” and each of the stockholders listed on Schedule B hereto, each of whom is referred to in this Agreement as a “Common Holder.”
TEMPUS AI, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • May 20th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc. • Delaware
This INDEMNIFICATION AGREEMENT (this “Agreement”) is dated as of , 20 and is between Tempus AI, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
STRATEGIC COLLABORATION AGREEMENT between GLAXOSMITHKLINE LLC and TEMPUS LABS, INC.Strategic Collaboration Agreement • May 20th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc. • Delaware
THIS STRATEGIC COLLABORATION AGREEMENT (the “Agreement”) is dated as of August 1, 2022 (the “Effective Date”) and made between GLAXOSMITHKLINE LLC, a limited liability company with its principal place of business located at 5 Crescent Drive, Philadelphia, PA 19112, United States (“GSK”); and TEMPUS LABS, INC., a corporation with its principal place of business located at 600 West Chicago Avenue, Chicago, Illinois 60654 (“Tempus”).
Master AgreementSubscription Agreement • May 20th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc. • Illinois
This Master Agreement (inclusive of all Exhibits and Order Forms, the “Agreement”) is entered into by and between Tempus Labs, Inc. (on behalf of itself and its affiliates, “Tempus”), and Recursion Pharmaceutical, Inc. (“Client” or “Recursion”). Tempus and Recursion are each individually a “Party” and are collectively the “Parties.”
MASTER SERVICES AGREEMENT Dated as of November 17, 2021 by and between ASTRAZENECA AB and TEMPUS LABS, INC.Master Services Agreement • May 20th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc. • Delaware
This Master Services Agreement (this “Agreement”), dated as of November 17, 2021 (the “Effective Date”), i s entered into by and between AstraZeneca AB, a company incorporated in Sweden under No. 556011-7482, whose registered office is at SE-151 86 Södertälje and with offices at SE-432 83 Mölndal, Sweden (“AstraZeneca”) and Tempus Labs, Inc., a Delaware corporation, located at 600 W Chicago Ave, Suite 510, Chicago, Illinois, 60654 (“Tempus” and together with AstraZeneca, the “Parties”, and each a “Party”).
CERTAIN PORTIONS OF THIS EXHIBIT (INDICATED BY ASTERISKS) HAVE BEEN OMITTED AS THE REGISTRANT HAS DETERMINED THAT THE INFORMATION IS BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Amendment to Master Services...Master Services Agreement • May 20th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc.
This Amendment to Master Services Agreement (“Amendment”) is made by and between AstraZeneca AB (“AstraZeneca”) and Tempus Labs, Inc. (“Tempus”) and amends the Master Services Agreement between the Parties with an effective date of November 17, 2021 (the “Agreement”).
CERTAIN PORTIONS OF THIS EXHIBIT (INDICATED BY ASTERISKS) HAVE BEEN OMITTED AS THE REGISTRANT HAS DETERMINED THAT THE INFORMATION IS BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Second Amendment to Master...Master Services Agreement • May 20th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc.
This Second Amendment to Master Services Agreement (“Amendment”) is made by and between AstraZeneca UK Ltd (“AstraZeneca”) and Tempus Labs, Inc. (“Tempus”) and amends the Master Services Agreement between the Parties with an effective date of November 17, 2021 (as amended, the “Agreement”).
CERTAIN PORTIONS OF THIS EXHIBIT (INDICATED BY ASTERISKS) HAVE BEEN OMITTED AS THE REGISTRANT HAS DETERMINED THAT THE INFORMATION IS BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Amendment to Master Services...Master Services Agreement • May 20th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc.
This third Amendment (“Amendment”) is made by and between AstraZeneca AB (“AstraZeneca”) and Tempus Labs, Inc. (“Tempus”) (together the “Parties”) and amends the Master Services Agreement between the Parties dated of November 17, 2021 as amended on 29 October 2022 and 21 February 2023 (the “Agreement”).
